Genetic variation in the adiponectin receptor 2 (ADIPOR2) gene is associated with coronary artery disease and increased ADIPOR2 expression in peripheral monocytes

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Halvatsiotis, Iosif ^a,b   Tsiotra, Panayoula C ^a   Ikonomidis, Ignatios ^b   Kollias, Anastasios ^a,b   Mitrou, Panagiota ^a   Maratou, Eirini ^a   Boutati, Eleni ^b   Lekakis, John ^b   Dimitriadis, George ^b   Economopoulos, Theofanis ^b   Kremastinos, Dimitrios T ^b   Raptis, Sotirios A ^a,b  

^a Hellenic National Center for the Research   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN RECEPTOR 2; CD14 ANTIGEN; MESSENGER RNA; ADIPONECTIN RECEPTOR; ADIPOR2 PROTEIN, HUMAN; LIPID;

ADULT; AGE; ALLELE; ALLELE SPECIFIC PRIMER EXTENSION; ANGIOCARDIOGRAPHY; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; FEMALE; FLOW CYTOMETRY; GENDER; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; GREECE; HETEROZYGOTE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MONOCYTE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST HIP RATIO; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; GENE FREQUENCY; GENETICS; HOMOZYGOTE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ANTIGENS, CD14; ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GREECE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; MONOCYTES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN; RNA, MESSENGER; WAIST-HIP RATIO;

EID: 77649310824     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-10     Document Type: Article

References (45)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749. 10.1074/jbc.270.45.26746, 7592907.
2. Hu E, Liang P, Spiegelman PM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1995, 27:110697-10703.
3. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose-specific collagen like factor, apM (Adipose Most Abundant Gene Trascriptant gene 1). Biochem Biophysl Res Commun 1996, 221:286-289.
4. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterisation of GBP28, a novel gelatin binding protein purified from human plasma. J Biochem 1996, 120:803-812.
5. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley R, Tataranni A. Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia. J Clin Endocrinol Metabol 2001, 86:1930-1935.
6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83. 10.1006/bbrc.1999.0255, 10092513.
7. Kumada M, Kihara S, Sumitsuji S. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89. 10.1161/01.ATV.0000048856.22331.50, 12524229.
8. Hara K, Yamauchi T, Imai Y, Manabe I, Kadowaki T. Reduced adiponectin level is associated with severity of coronary artery disease. Int Heart J 2007, 48:149-153. 10.1536/ihj.48.149, 17409580.
9. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-95. 10.1038/nm788, 12368907.
10. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein, adiponectin. Circulation 1999, 100:2473-2476.
11. Ouchi N, Kihara S, Funahashi T. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte derived macrophages. Circulation 2001, 103:1057-1063.
12. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipovascular axis. J Biol Chem 2002, 277:37487-37491. 10.1074/jbc.M206083200, 12138120.
13. Çattori Y, Suzuki M, Hattori S, Kasai K. Globular adiponectin upregulates nitric oxide production in vascular endothelial cells. Diabetologia 2003, 46:1543-1549. 10.1007/s00125-003-1224-3, 14551684.
14. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000, 96:1723-1732.
15. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769. 10.1038/nature01705, 12802337.
16. Blüher M, Bullen JW, Lee JH, Kralisch S, Fasshauer M, Klotting N, Niebauer J, Schon MR, Williams CJ, Mantzoros CS. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metabol 2006, 91:2310-2316.
17. Blüher M, Williams CJ, Kloting N, Hsi A, Ruschke K, Oberbach A, Fasshauer M, Berndt J, Schon MR, Wolk A, Stumvoll M, Mantzoros C. Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training. Diabetes Care 2007, 30:3110-3115. 10.2337/dc07-1257, 2732345, 17878241.
18. Nannipieri M, Bonotti A, Anselmino M, Cecchetti F, Madec S, Mancini E, Baldi S, Santini F, Pinchera A, Rossi M, Ferrannini E. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state. Int J Obes 2007, 31:1843-1848.
19. Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS. Up regulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin resistant women with polycystic ovarian syndrome. Diabetologia 2006, 49:2723-2728. 10.1007/s00125-006-0419-9, 17001470.
20. Civitarese AE, Jenkinson C, Richardson T, Bajaj M, Cusi K, Kashyap S, Berria R, Belfort R, DeFronzo RA, Mandarino LJ, Ravussin E. Adiponectin receptors gene expression and insulin sensitivity in non diabetic Mexican Americans with or without a family history of type 2 diabetes. Diabetologia 2004, 47:816-820. 10.1007/s00125-004-1359-x, 15105989.
21. Weigert J, Neumeier M, Wanninger J, Wurm S, Kopp A, Schobber F, Filarsky M, Schaffler A, Zeitun N, Aslanidis C, Buechler C. Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. FEBS Letters 2008, 582:1777-1782. 10.1016/j.febslet.2008.04.031, 18442481.
22. Damcott CM, Ott SH, Pollin T, Reinhart LJ, Wang J, O'Connell JR, Mitchel BD, Shuldiner AR. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the old order Amish. Diabetes 2005, 54:2245-2250. 10.2337/diabetes.54.7.2245, 15983228.
23. Vaxillaire M, Dechaume A, Vasseur-Delannoy V, Lahmidi S, Vatin V, Lepretre F, Boutin P, Hercberg S, Charpentier G, Dina C, Froguel P. Genetic analysis of ADIPOR1 and ADIPOR2 candidate polymorphisms for type 2 diabetes in the Caucasian population. Diabetes 2006, 55:856-861. 10.2337/diabetes.55.03.06.db05-0665, 16505255.
24. Liao YF, Chen LL, Zeng TS, Zheng J, Li HQ. Association of the +33371 A/G polymorphism in adiponectin receptor 2 gene with Type 2 diabetes in the Chinese population. J Endocrinol Invest 2007, 30:860-864.
25. Kotronen A, Yki-Jarvinen H, Aminoff A, Bergholm R, Pietilainen KH, Westerbacka J, Talmud PJ, Humphries SE, Hamsten A, Isomaa B, Groop L, Orho-Melander M, Ehrenborg E, Fisher RM. Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. Eur J Endocrinol 2009, 160:593-602. 10.1530/EJE-08-0900, 19208777.
26. Lopez-Bermejo A, Botas-Cervero P, Ortega-Delgado F, Delgado E, García-Gil MM, Funahashi T, Ricart W, Fernández-Real. Association of ADIPOR2 with liver function tests in type 2 diabetic subjects. Obesity 2008, 16:2308-2313. 10.1038/oby.2008.344, 18719649.
27. Broedl UC, Lehrke M, Fleischer-Brielmaier E, Tietz AB, Nagel JM, Göke B, Lohse P, Parhofer KG. Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome. Cardiovasc Diabetol 2006, 5:11. 10.1186/1475-2840-5-11, 1482678, 16700915.
28. Richardson DK, Schneider J, Fourcaudot MJ, Rodriguez LM, Arya R, Dyer TD, Almasy L, Blangero J, Stern MP, DeFronzo RA, Duggirala R, Jenkinson CP. Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia 2006, 49:2317-2328. 10.1007/s00125-006-0384-3, 16955209.
29. Kim JT, Kim Y, Cho YM, Koo BK, Lee EK, Sin HD, Jang C, Choi JW, Oh B, Park KS. Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans. Clin End 2009, 70:66-74.
30. Stefan N, Machicao F, Staiger H, Machann J, Schick F, Tschritter O, Spieth C, Weigert C, Fritsche A, Stumvoll M, Häring HU. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetes 2005, 48:2282-2291.
31. Collins SC, Luan J, Thomson AJ, Daly A, Semple RK, O'Rahilly S, Wareham NJ, Barroso I. Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations. Diabetologia 2007, 50:555-562. 10.1007/s00125-006-0534-7, 1794135, 17216283.
32. Hara K, Horikoshi M, Kitazato H, Yamauchi Tnoda M, Ohashi J, Froguel P, Nagai R, Kadowaki T. Absence of an association between the polymorphisms in the genes encoding adiponectin receptors and type 2 diabetes. Diabetologia 2005, 48:1307-1314. 10.1007/s00125-005-1806-3, 15918014.
33. Qi L, Doria A, Giorgi E, Hu F. Variations in adiponectin receptor genes and susceptibility to type 2 diabetes in women: A tagging- SNP haplotype analysis. Diabetes 2007, 56:1586-1591. 10.2337/db06-1447, 17416799.
34. Lekakis JP, Ikonomidis I, Tsibida M, Protogerou A, Papada A, Papapanagiotou A, Revela I, Papamichael CM, Kalofoutis AT, Kremastinos DT. Genetic variations of the endothelial nitric oxide synthase gene are related to increased levels of C-reactive protein and macrophage-colony stimulating-factor in patients with coronary artery disease. Thromb Haemost 2006, 96:520-8.
35. Ikonomidis I, Lekakis JP, Nikolaou M, Paraskevaidis I, Andreadou I, Kaplanoglou T, Katsimbri P, Skarantavos G, Soucacos PN, Kremastinos DT. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 2008, 117:2662-9. 10.1161/CIRCULATIONAHA.107.731877, 18474811.
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
37. Matsuda M, De Fronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999, 22:1462-1470. 10.2337/diacare.22.9.1462, 10480510.
38. Iannone MA, Taylor JD, Chen J, Li MS, Ye F, Weiner MP. Microsphere-based single nucleotide polymorphism genotyping. Methods Mol Biol 2003, 226:123-134.
39. Cai H, White PS, Torney D, Deshpande A, Wang Z, Marrone B, Nolan JP. Flow cytometry-based minisequencing: a new platform for high-throughput single-nucleotide polymorphism scoring. Genomics 2000, 66:135-143. 10.1006/geno.2000.6218, 10860658.
40. Tsiotra PC, Tsigos C, Yfanti E, Anastasiou E, Vikentiou M, Psarra K, Papasteriades C, Raptis SA. Visfatin, TNF-alpha IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Horm Metab Res 2007, 39:758-763. 10.1055/s-2007-990288, 17952840.
41. Rodriguez S, Gaunt RT, Day NMI. Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies. Am J Epidemiol 2009, Advance Access published on January 6, DOI 10.1093/aje/kwn359, 2640163, 19126586.
42. Yamauchi T, Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 2008, 32:S13-S18. 10.1038/ijo.2008.233, 19136982.
43. Soccio T, Zhang YY, Bacci S, Miynarski W, Placha G, Raio T, Di Paola R, Marucci A, Johnstone MT, Klein S, Triscitta V, Doria A. Common Haplotypes at the Adiponectin Receptor 1 (ADIPOR1) Locus are associated with increased risk of Coronary Artery Disease in Type 2 Diabetes. Diabetes 2006, 55:2763-2770. 10.2337/db06-0613, 17003341.
44. Djaberi R, Beishuizen ED, Pereira AM, Rabelink TJ, Smit JW, Tamsma JT, Huisman MV, Jeiken JW. Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia 2008, 51:1581-1593. 10.1007/s00125-008-1062-4, 2516193, 18607561.
45. de Groot E, van Leuven SI, Duivenvorden R, Meuwese MC, Akdim F, Bots ML, Kastelein JJ. Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis. Nat Clin Pract Cardiovasc Med 2008, 5:280-288. 10.1038/ncpcardio1163, 18332891.